Anticoagulant effects on the evaluation of CD23 expression in cells by monoclonal antibodies

Leuk Lymphoma. 2022 Jul;63(7):1742-1745. doi: 10.1080/10428194.2022.2038379. Epub 2022 Feb 11.

Authors

Katsushi Tajima^{1

2}, Kiwa Tanaka³, Hikaru Takeda³, Mika Moriya³, Tetsuya Ueki³, Shinya Ogata⁴, Kunihiko Maeda⁵, Takeshi Yasuda²

Affiliations

¹ Department of Hematology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
² National Institute for Quantum Science and Technology, Chiba, Japan.
³ Department of Laboratory Medicine, Yamagata Prefectural Central Hospital, Yamagata, Japan.
⁴ Department of Pathology, Yamagata Prefectural University of Health Sciences, Yamagata, Japan.
⁵ Department of Physical Therapy, Yamagata Prefectural University of Health Sciences, Yamagata, Japan.

PMID: 35147494
DOI: 10.1080/10428194.2022.2038379

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal* / pharmacology
Antibodies, Monoclonal* / therapeutic use
Anticoagulants / pharmacology
Anticoagulants / therapeutic use
Antigens, Differentiation, B-Lymphocyte
Antineoplastic Agents, Immunological*
Humans
Receptors, IgE / metabolism

Substances

Antibodies, Monoclonal
Anticoagulants
Antigens, Differentiation, B-Lymphocyte
Antineoplastic Agents, Immunological
Receptors, IgE